eFFECTOR Therapeutics, Inc. (EFTR) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts EFTR Hot Sheet
Join SI Premium – FREE
eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13).
For earnings history and earnings-related data on eFFECTOR Therapeutics, Inc. (EFTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SolarMax Technology (SMXT) Misses Q2 EPS by 98c
- Marvell Technology shares fall on valuation concerns
- Duke Energy (DUK) PT Lowered to $130 at Truist Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
